Campbell & Co. Investment Adviser »

Ptc Therapeutics I shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $205k 3.3k 61.37
2025-06-30 $727k 15k 48.84
2024-12-31 $412k 9.1k 45.14
2024-09-30 $376k 10k 37.10
2022-12-31 $517k 14k 38.17
2022-09-30 $1.1M 21k 50.21
2022-06-30 $374k 9.3k 40.08

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Ptc Therapeutics I

Vanguard Group
Rtw Investments
BlackRock
Wellington Management Company
Henderson Group
Armistice Capital
Toronto-Dominion Bank
State Street Corporation
D. E. Shaw & Co
Geode Capital Management
Citadel Advisors
FMR
Leucadia National Corporation
Tang Capital Management
Pictet Asset Management Holding SA

View all funds holding Ptc Therapeutics I